Published By : 06 Jul 2017 | Published By : QYRESEARCH
Maryland regulators have given a nod to a Frederick company to open doors to the state’s first medical marijuana dispensary. The Wellness Institute of Maryland will start attending to patients Thursday and taking preorders for cannabis, although the drug will not be available until September. The institute has also planned to home deliver the drug for qualified patients once available.
Second grower in Baltimore Country, Curio Wellness, however, has been delayed for license by the Maryland Medical Cannabis Commission due to some missing information, although a state inspector approved the facility last month. Failure to approve Curio’s stage two license has been deemed by CEO Michael Bronfein to delay patients of receiving effective, reliable, and safe medicine.
Companies awarded 15 preliminary processing and 15 preliminary growing licenses have been given August 15 as the deadline to secure a final license, failing which they could lose out of a lucrative market. 102 companies selected for dispensary distribution, however, will not face the same time limit.
Efforts to Broaden Access to Medical Marijuana Not Backed Enough
Closely 9,000 patients have been registered for medical marijuana in Maryland, excluding lawfully permissible out-of-state patients. However, regulators have been reconsidering laws concerning the issuance of the drug to out-of-state patients in view of potential frauds. Moreover, only 300 doctors have agreed to recommend the drug, which is a mere 2.0% of the 16,000 physicians practicing in the state. Last month, nurse practitioners, mid-wives, podiatrists, and dentists were authorized to recommend the drug under a new law. However, only 20 professionals have signed up for it.
Meanwhile, a discrimination and reasonable disability accommodation failure lawsuit was filed in Bridgeton, New Jersey against Ardagh Glass, Inc. by a general utility worker who was laid off for using medical marijuana prescribed by his doctor as part of Marfan syndrome (MFS) treatment.
Certainly, there is a need for quick yet legitimate approvals in the U.S., so eligible patients are not deprived of the treatments and drugs they desperately need. “The clock is ticking,” said Maryland Medical Cannabis Commission executive director. The commission has planned to make more frequent visits to approve providers for licenses after their final state inspection.